Please login to the form below

Not currently logged in
Email:
Password:

HIV

This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.

GSK sells eczema and psoriasis drug to Dermavant for £250m

GSK sells eczema and psoriasis drug to Dermavant for £250m

GSK’s tighter focus on respiratory, HIV, oncology, and vaccines has already seen it cull 30 pipeline programmes and offload its rare disease assets to Orchard Therapeutics.

Latest news

  • Trial data suggest Abivax’ drug may clear latent HIV Trial data suggest Abivax’ drug may clear latent HIV

    That means that despite enormous advances in drug treatment people with HIV are consigned to lifelong treatment to keep the virus in check. ... HIV of between 2% and 85%, while four saw an increase ranging from 5% to 36%.

  • Gilead’s Biktarvy gets European approval, setting up battle with GSK Gilead’s Biktarvy gets European approval, setting up battle with GSK

    The drug could offset Gilead's disappointing hep C franchise. Gilead has gained European approval for its new HIV combination therapy Biktarvy, hot on the heels of GSK's rival Juluca. ... Alan Winston, Professor of HIV and Genitourinary Medicine at

  • 90TEN celebrates double win for HIV campaign at Communiqué 2018 90TEN celebrates double win for HIV campaign at Communiqué 2018

    90TEN celebrates double win for HIV campaign at Communiqué 2018. The agency picks up awards in Excellence in Patient/Consumer Health Programmes and Excellence in Social Media Strategy. ... 90TEN’s HIV campaign My Journey: Flight HIV101 picked up two

  • The year of the blockbuster The year of the blockbuster

    The diseases targeted by the report’s projected market entrants include type 2 diabetes, endometriosis, childhood epilepsy, haemophilia, HIV, migraine, opioid addiction and shingles. ... It is forecast to achieve sales in excess of $3bn and should help

  • Patient engagement hygiene factors Patient engagement hygiene factors

    There are great examples of pharma rising to this challenge with engagement programmes, particularly in the field of rare diseases and HIV, that are changing old perceptions and breaking new ground.

More from news
Approximately 80 fully matching, plus 531 partially matching documents found.

Latest Intelligence

  • Advancing women in healthcare Advancing women in healthcare

    Gerberding’s talent as a doctor and a public health leader first became apparent while working at the frontline of the HIV/AIDs crisis in the 1980s, to leading the US

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    One of the outstanding clinical trialists and epidemiologists of her generation, Prof Janet Darbyshire’s expertise in research methodology has led to improved prevention and treatment of diseases such as HIV

  • No incentive for a cure No incentive for a cure

    Type 1 diabetes, heart failure, HIV - all examples of diseases that have transitioned from fatal conditions to chronic diseases, thanks to the progress in modern medicine.

  • The cultural construction of illness The cultural construction of illness

    We once worked with a team marketing a product for people with HIV. ... Their advertising was failing to cut through and it became clear to us that one of the reasons for this was its depiction of happy, calm people living with HIV, but

  • Not dying of ignorance - 30 years on Not dying of ignorance - 30 years on

    Not dying of ignorance - 30 years on. Behavioural changes with HIV and AIDS. ... And EastEnders character Mark Fowler coming out as HIV positive had a massive impact, resulting in thousands of people being tested.

More from intelligence
Approximately 2 fully matching, plus 40 partially matching documents found.

Latest appointments

  • Aelix Therapeutics appoints Dr Thomas Hecht Aelix Therapeutics appoints Dr Thomas Hecht

    its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the

  • emotive boosts its client services team emotive boosts its client services team

    Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.

  • GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet

    GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet. She will become CEO designate at the HIV-focused firm in January. ... GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down

  • Bionor names executive management team additions Bionor names executive management team additions

    HIV and deadly virus firm Bionor Pharma has revealed a number of new additions to its executive management team. ... Together, they bring a wealth of experience to advance therapeutic vaccines for Bionor, and specifically will add operational strength to

  • MHP Health strengthens team with four hires MHP Health strengthens team with four hires

    She also volunteers for two HIV charities: one based in London, which supports young people who have family members affected by HIV and one that supports the work of people in

More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 33 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics